Introduction

Movement Disorders

Volumn 17, Issue SUPPL. 4, 2002, Pages

  Goetz, C G ^a   Koller, W C ^a   Poewe, W ^a   Rascol, O ^a   Sampaio, C ^a   Brin, M F ^a   Lees, Andrew J ^a   LeWitt, P ^a   Lozano, A ^a   Mizuno, Y ^a   Nutt, J ^a   Oertel, W ^a   Olanow, C W ^a   Tolosa, E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; APOMORPHINE; BROMOCRIPTINE; CABERGOLINE; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIHYDROERGOCRYPTINE; ERGOT DERIVATIVE; HYPERTENSIVE AGENT; LEVODOPA; LISURIDE; MONOAMINE OXIDASE B INHIBITOR; NEUROLEPTIC AGENT; PERGOLIDE; PIRIBEDIL; PRAMIPEXOLE; ROPINIROLE;

AUTONOMIC DYSFUNCTION; BRAIN DEPTH STIMULATION; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; COCHRANE LIBRARY; DEMENTIA; DEPRESSION; EDITORIAL; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL LITERATURE; META ANALYSIS; MOTOR DYSFUNCTION; NERVE TRANSPLANTATION; OUTCOMES RESEARCH; PALLIATIVE THERAPY; PARKINSON DISEASE; PATIENT COUNSELING; PHYSIOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOSIS; PUBLICATION; SPEECH THERAPY; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0036920370     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.5555     Document Type: Editorial

References (14)

1. Cohen N, Almoznino-Sarafian D, Alon I, et al. Warfarian for stroke prevention still underused in atrial fibrillation: patterns of omission. Stroke 2000;31(6):1217-22.
2. Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA 1992;4:268(17):2420-5.
3. Evidence-Based Medicine: How to Practice and Teach EBM (2nd Edition). Sackett DK, Straus S, Richardson S, Rosenberg W, Haynes RB. London, eds. Churchill Livingstone. 2000; p. 1.
4. Cook DJ, Mulrow CD, Haynes B. Synthesis of best evidence for clinical decisions. In Systematic Reviews, Synthesis Of Best Evidence For Health Care Decisions. Mulrow CD, Cook DJ, eds. American College of Physicians, 1998.
5. SIGN Guidelines: An Introduction To SIGN Methodology For The Development Of Evidence-Based Clinical Guidelines. Edinburgh Scotland. Scottish Intercollegiate Guidelines Network (SIGN); 1999. 33(SIGN publications, 39).
6. Clarke CE, Sampaio C. Movement Disorders Cochrane Collaborative Review Group. Mov Disord 1997;12:477-482.
7. Jadad AR, Moher M, Browman GP, et al. Systematic reviews and meta-analyses on treatment of asthma: critical evaluation. BMJ 2000;320:537-540.
8. Stern JM, Simes RJ. Publication bias: evidence of delayed publication in a cohort study of clinical research projects. BMJ 1997;315:640-645.
9. Grǵoire G, Derderian F, LeLorier J. Selecting the language of the publications included in a meta-analysis: is there a tower a Babel bias? J Clin Epidemiol 1995;48:159-63.
10. Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G. Language bias in randomized controlled trials published in English and German. Lancet 1997;350:326-329.
11. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309:1286-91.
12. Wolf SH, Battista RN, Anderson CM, Logan AG, Wang E and The Canadian Task Force on the periodic health examination. Assessing the clinical effectiveness of preventive manoeuvres: analytical principles and systematic methods in reviewing evidence and developing clinical practice recommendations. J Clin Epidemiology 43:891-905.
13. Dixon RA, Munro JF, Silcocks RP. Checklists for Critical Appraisal. The Evidence Based Medicine Workbook: Critical Appraisal for Clinical Problem Solving. Butterworth-Heinemann Medical 1997, Appendix I.
14. Kaufman DW, Shapiro S. Epidemiological assessment of drug-induced disease. Lancet 2000;356(9238):1339-43.